North America Idiopathic Thrombocytopenic Purpura Therapeutics Market Size & Outlook
Related Markets
North America idiopathic thrombocytopenic purpura therapeutics market highlights
- The North America idiopathic thrombocytopenic purpura therapeutics market generated a revenue of USD 257.5 million in 2023.
- The market is expected to grow at a CAGR of 4.5% from 2024 to 2030.
- In terms of segment, acute itp was the largest revenue generating disease type in 2023.
- Acute ITP is the most lucrative disease type segment registering the fastest growth during the forecast period.
North America data book summary
| Market revenue in 2023 | USD 257.5 million |
| Market revenue in 2030 | USD 349.7 million |
| Growth rate | 4.5% (CAGR from 2023 to 2030) |
| Largest segment | Acute itp |
| Fastest growing segment | Acute ITP |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Acute ITP |
| Key market players worldwide | Amgen Inc, Roche, Grifols SA Ordinary Shares - Class A, GSK PLC, Intromedic, Medtronic PLC, FUJIFILM Holdings Corp, Olympus Corp |
Other key industry trends
- In terms of revenue, North America region accounted for 39.7% of the global idiopathic thrombocytopenic purpura therapeutics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 193.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Idiopathic Thrombocytopenic Purpura Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | http://www.roche.com |
| Grifols SA Ordinary Shares - Class A | View profile | 23737 | Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, Spain, 08174 | https://www.grifols.com |
| Intromedic | View profile | - | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | http://www.intromedic.co.kr |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| FUJIFILM Holdings Corp | View profile | 83784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | http://www.fujifilmholdings.com |
| Olympus Corp | View profile | 33629 | Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, Japan, 163-0914 | http://www.olympus.co.jp |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
North America idiopathic thrombocytopenic purpura therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to idiopathic thrombocytopenic purpura therapeutics market will help companies and investors design strategic landscapes.
Acute itp was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America idiopathic thrombocytopenic purpura therapeutics market based on acute itp covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to North America idiopathic thrombocytopenic purpura therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America idiopathic thrombocytopenic purpura therapeutics market databook
-
Our clientele includes a mix of idiopathic thrombocytopenic purpura therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America idiopathic thrombocytopenic purpura therapeutics market , including forecasts for subscribers. This continent databook contains high-level insights into North America idiopathic thrombocytopenic purpura therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
